
FDA approves updated COVID-19 shots for seniors and high-risk individuals
Published on: Aug. 28, 2025, 12:07 a.m. | Source: India Today
The FDA has approved new COVID-19 vaccines from Pfizer, Moderna, and Novavax for people above 65 years of age and high-risk individuals, aiming to mitigate health risks.